Abstract
Purpose
With extensive use of systemic treatment, the issue of cardiac mortality after breast cancer radiation (RT) is still important. The aim of our analysis was to clarify whether the dose to one surrogate parameter (e. g., mean heart dose, as used in most studies) reflects the dose to the other cardiovascular structures especially the left anterior descending artery depending on breathing-adapted RT.
Patients and methods
A total of 130 patients who underwent adjuvant RT (50.4 Gy plus boost 9–16 Gy) were evaluated. In all, 71 patients were treated with free-breathing and 59 patients using respiratory monitoring (gated RT). Dosimetric associations were calculated.
Results
The mean dose to the heart (Dmean heart) was reduced from 2.7 (0.8–5.2) Gy to 2.4 (1.1–4.6) Gy, the Dmean LAD (left anterior descending artery) decreased from 11.1 (1.3–28.6) Gy to 9.3 (2.2–19.9) Gy with gated RT (p = 0.04). A significant relationship was shown for Dmean heart–Dmean LAD, V25heart–Dmean LAD and Dmax heart–Dmax LAD for gated patients only (p < 0.01). For every 1 Gy increase in Dmean heart, mean LAD doses rose by 3.6 Gy, without gating V25 ≤5 % did not assure a benefit and resulted in Dmean LAD between 1.3 and 28.6 Gy.
Conclusion
A significant reduction and association of heart and coronary artery (LAD) doses using inspiratory gating was shown. However, in free-breathing plans commonly measured dose constraints do not allow precise estimation of the dose to the coronary arteries.
Zusammenfassung
Hintergrund
Das Risiko kardialer Spätfolgen nach Bestrahlung (RT) eines Mammakarzinoms spielt insbesondere auch aufgrund der zunehmenden systemischen Begleittherapien eine wichtige Rolle. Unklar ist, welche koronaren und/oder myokardialen Mechanismen hier entscheidend sind. Der Einfluss der Atemtriggerung und der daraus resultierenden geometrischen Lagevariabilität der Risikoorgane auf die Dosisverteilung am Herzen/Koronarien sollte geprüft werden, um zu klären, inwieweit die mittlere Herzdosis ein ausreichender Surrogatparameter für die Dosisbelastung der Koronarien ist.
Patienten und Methoden
Ausgewertet wurden 130 Patientinnen mit Mammakarzinom, die mit einer adjuvanten RT (50,4 Gy + Boost 9–16 Gy) bestrahlt wurden. Hiervon wurden 71 Patientinnen in freier Atmung und 59 Patientinnen inspiratorisch atemgetriggert bestrahlt. Des Weiteren wurde die kardiale/koronare Dosisbelastung mit und ohne Atemtriggerung verglichen.
Ergebnisse
Die mittlere Herdosis (Dmean Herz) wurde durch Atemtriggerung von 2,7 Gy (Spanne 0,8–5,2 Gy) auf 2,4 Gy (Spanne 1,1–4,6 Gy) reduziert. Die mittlere LAD-Dosis („left anterior descending artery“, Ramus interventricularis anterior, RIVA) nahm mit Atemtriggerung von 11,1 Gy (Spanne 1,3–28,6 Gy) auf 9,3 Gy (Spanne 2,2–19,9 Gy) ab (p = 0,04). Die Dosisparameter Dmean Herz – Dmean LAD, V25 Herz – Dmean LAD und Dmax Herz – Dmax LAD waren nur für atemgetriggerte Fälle signifikant korrelierbar (p < 0,01), mit einem durchschnittlichen Anstieg der mittleren LAD-Dosis von 3,6 Gy pro 1 Gy mittlere Herzdosis. Bei einer nicht-atemgetriggerten RT lagen die mittleren LAD-Dosen zwischen 1,3 und 28,6 Gy trotz V25 ≤5 %.
Schlussfolgerung
Unter Einsatz einer atemgetriggerten Bestrahlungstechnik lassen sich sowohl die mittlere Herz- als auch die LAD-Dosis senken und die kardialen Dosisparameter miteinander korrelieren. Für die RT ohne Atemtriggerung lässt sich die LAD-Belastung jedoch nicht sicher abschätzen.
Similar content being viewed by others
References
Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241
Clarke M, Collins R, Darby S et al (2005) Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–2106
Taylor C, Nisbet A, McGale P et al (2009) Cardiac doses from Swedish breast cancer radiotherapy since the 1950s. Radiother Oncol 90:127–135
Doyle J, Neugut A, Jacobsen S et al (2007) Radiation therapy, cardiac risk factors and cardiac toxicity in early-stage breast cancer patients. Int J Radiat Oncol Biol Phys 68:82–93
Budach W, Bölke E, Kammers K et al (2015) Adjuvant radiation therapy of regional lymph nodes in breast cancer – a meta-analysis of randomized trials – an update. Radiat Oncol 10(1):258
Korreman S, Pedersen A, Aarup L et al (2006) Reduction of cardiac and pulmonary complication probabilities after breathing adapted radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys 65:1375–1380
Darby SC, Ewertz M, McGale P et al (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368(11):987–998
Schultz-Hector S, Trott KR (2007) Radiation induced cardiovascular diseases: Is the epidemiologic evidence compatible with the radiobiological data? Int J Radiat Oncol Biol Phys 67:10–18
Yeung R, Long K, Walrath D et al (2014) Evaluation of cardiac dose reduction with deep inspiration breath hold in patients with left-sided breast cancer receiving adjuvant radiotherapy. J Clin Oncol 32(5s):1096
Feng M, Moran JM, Koelling T et al (2011) Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys 79(1):10–18. doi:10.1016/j.ijrobp.2009.10.058
Beck R, Lim L, Yue N et al (2014) Treatment techniques to reduce cardiac irradiation for breast cancer patients treated with breast conserving surgery and radiation therapy: a review. Front Oncol doi:10.3389/fonc.2014.00327
Marks LB, Yorke ED, Jackson A et al (2010) Quantitative analysis of normal tissue effects in the clinic updated guidelines. Int J Radiat Oncol Biol Phys 76(3):10–19. doi:10.1016/j.ijrobp.2009.07.1754
Lorenzen EL, Taylor CW, Maraldo M et al (2013) Inter-observer variation in delineation of the heart and left anterior descending coronary artery in radiotherapy for breast cancer: a multi-centre study from Denmark and the UK. Radiother Oncol 108(2):254–258
Nielsen MH, Berg M, Pedersen AN et al (2013) Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: national guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group. Acta Oncol 52(4):703–710
Moorthy S, Sakr H, Hasan S et al (2013) Dosimetric study of SIB-IMRT versus SIM-3DCRT for breast cancer with breath-hold gated technique. Int J Cancer Ther Oncol 1(1):010110
Fung E, Hendry J (2013) External beam radiotherapy (EBRT) techniques used in breast cancer treatment to reduce cardiac exposure. Radiography 19:73–78
Smyth LM, Knight KA, Aarons YK, Wasiak J (2015) The cardiac dose-sparing benefits of deep inspiration breath-hold in left breast irradiation: a systematic review. J Med Radiat Sci 62(1):66–73
Sardaro A, Petruzzelli MF, D’Errico MP et al (2012) Radiation-induced cardiac damage in early left breast cancer patients: risk factors, biological mechanisms, radiobiology, and dosimetric constraints. Radiother Oncol 103:133–142
Swanson T, Grills IS, Ye H et al (2013) Six-year experience routinely using moderate deep inspiration breath-hold for the reduction of cardiac dose in left-sided breast irradiation for patients with early-stage or locally advanced breast cancer. Am J Clin Oncol 36:24–30
Hjelstuen MH, Mjaaland I, Vikstrom J, Dybvik KI (2012) Radiation during deep inspiration allows loco-regional treatment of left breast and axillary-, supraclavicular- and internal mammary lymph nodes without compromising target coverage or dose restrictions to organs at risk. Acta Oncol 51:333–344
Qi XS, Hu A, Wang K, Newman F et al (2012) Respiration induced heart motion and indications of gated delivery for left-sided breast irradiation. Int J Radiat Oncol Biol Phys 82(5):1605–1611
Evans SB, Panigrahi B, Northrup V et al (2013) Analysis of coronary artery dosimetry in the 3‑dimensional era: implications for organ-at-risk segmentation and dose tolerances in left-sided tangential breast radiation. Pract Radiat Oncol 3(2):e55–e60
Correa CR, Litt HI, Hwang WT et al (2007) Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer. J Clin Oncol 25(21):3031–3037
Lind PA, Pagnanelli R, Marks LB et al (2003) Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution. Int J Radiat Oncol Biol Phys 55(4):914–920
Correa CR, Das IJ, Litt HI et al (2008) Association between tangential beam treatment parameters and cardiac abnormalities after definitive radiation treatment for left-sided breast cancer. Int J Radiat Oncol Biol Phys 72(2):508–516
Prosnitz R, Hubbs I, Evans E et al (2007) Prospective assessment of radiotherapy-associated cardiac toxicity in breast cancer patients: analysis of data 3 to 6 years after treatment. Cancer 110:1840–1850
Aznar MC, Korreman SS, Pedersen A et al (2011) Evaluation of dose to cardiac structures during breast irradiation. Br J Radiol 84(1004):743–746
Nilsson G, Holmberg L, Garmo H et al (2012) Distribution of coronary artery stenosis after radiation for breast cancer. Clin Oncol 30(4):380–386
Zagar TM, Marks LB (2012) Breast cancer radiotherapy and coronary artery stenosis: location, location, location. J Clin Oncol 30(4):350–352
Taylor CW, Povall JM, McGale P et al (2008) Cardiac dose from tangential breast cancer radiotherapy in the year 2006. Int J Radiat Oncol Biol Phys 72(2):501–507
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
M. Becker-Schiebe, M. Stockhammer, W. Hoffmann, F. Wetzel, and H. Franz declare that they have no competing interests.
Ethical standards
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Becker-Schiebe, M., Stockhammer, M., Hoffmann, W. et al. Does mean heart dose sufficiently reflect coronary artery exposure in left-sided breast cancer radiotherapy?. Strahlenther Onkol 192, 624–631 (2016). https://doi.org/10.1007/s00066-016-1011-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-016-1011-y